뉴스벤징가
Sionna Therapeutics Discontinues Cystic Fibrosis Drug Following Unfavorable Data Data, Stock Tanks
· 발표
기사 요약
Sionna Therapeutics topline clinical data for cystic fibrosis programs disappoints, opting to discontinue its SION-719 candidate.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…